Chairman of the Board Research and Development and Production Committee
Dr. Michael Rosenblatt joined the Ferring Board of Directors in July, 2024. He was formerly Chief Medical Officer at Merck & Co., Inc, a professor of medicine at Harvard Medical School and dean of Tufts University School of Medicine. Prior to joining Ferring, Dr. Rosenblatt was Chief Medical Officer at Flagship Pioneering where he has served on the board of directors of several of its portfolio companies. Over the course of his career, he has also served as a founding scientist, scientific advisory board member, and director of a number of biopharmaceutical companies. Dr. Rosenblatt earned his M.D. magna cum laude from Harvard.
